Sanofi SA at Cowen Healthcare Conference (Virtual) Transcript
Good afternoon, and welcome back. We're very pleased to have with us, once again this year, Sanofi. Representing the company is Bill Sibold, who's Executive Vice President and Head of Sanofi Genzyme; and Frank Nestle, who is Head of Research and Chief Scientific Officer.
There are many, many positive developments underway at Sanofi, and we're eager to dive into each and learn more about all of them.
Questions & Answers
So without further ado, let me start out with the obligatory, big picture question I guess I'll put it to Bill. When you in peer in your crystal ball over the next 4 years, what do you think could emerge from the Biden administration relative to pricing? And what impact would it have on Sanofi?
Well, first of all, Steve, thanks for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
